Fertility protection. A multidisciplinary challenge;Fertilitätsprotektion. Eine multidisziplinäre herausforderung

Gynakologische Endokrinologie

Volumn 4, Issue 4, 2006, Pages 189-196

  Von Wolff, M ^a   Strowitzki, T ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cancer; Cytotoxic therapies; Fertility preservation; Ovarian protection

Indexed keywords

ALKYLATING AGENT; ANTIMETABOLITE; ANTIMITOTIC AGENT; BUSULFAN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DNA TOPOISOMERASE INHIBITOR; EPIRUBICIN; FLUOROURACIL; GONADORELIN DERIVATIVE; IFOSFAMIDE; METHOTREXATE; TAXANE DERIVATIVE; TOPOTECAN; TREOSULFAN; VINCRISTINE;

ARTICLE; CANCER THERAPY; CRYOPRESERVATION; FEMALE FERTILITY; FERTILIZATION IN VITRO; GERMANY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE MATURATION; PRESERVATION; PSYCHOLOGICAL ASPECT; REPRODUCTION; REPRODUCTIVE TOXICITY; TERATOGENICITY; VITRIFICATION;

EID: 33845379919     PISSN: 16102894     EISSN: 16102908     Source Type: Journal    
DOI: 10.1007/s10304-006-0160-y     Document Type: Article

References (42)

1. Ataya K, Ramahi-Ataya A (1993) Reproductive performance of female rats treated with cyclophosphamide and/or LHRH agonist. Reprod Toxicol 7: 229-235
2. Ataya K, Rao LV, Lawrence E et al. (1995) Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 52: 365-372
3. Baka SG, Toth TL, Veeck LL et al. (1995) Evaluation of the spindle apparatus of in-vitro matured human oocytes following cryopreservation. Hum Reprod 10: 1816-1820
4. Belinson JL, Doherty M, McDay JB (1984) A new technique for ovarian transposition. Surg Gynecol Obstet 159: 157-160
5. Blumenfeld Z, Dann E, Avivi I et al. (2002) Fertility after treatment for Hodgkin's disease. Ann Oncol 13 [Suppl 1]: 138-147
6. Bokser L, Szende B, Schally AV (1990) Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats. Br J Cancer 61: 861-865
7. Byrne J, Rasmussen SA, Steinhorn SC et al. (1998) Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet 62: 45-52
8. Cha KY, Han SY, Chung HM et al. (2000) Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome. Fertil Steril 73: 978-983
9. Chambers SK, Chambers JT, Holm C et al. (1990) Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients. Gynecol Oncol 39: 155-159
10. Chian RC, Buckett WM, Tulandi T et al. (2000) Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod 15: 165-170
11. Deutsches IVF-Register: http://www.deutsches-ivf-register.de
12. Donnez J, Dolmans MM, Demylle D et al. (2004) Live-birth after orthotopic transplantation of cryopreserved ovaria tissue. Lancet 364: 1405-1410
13. Dubrova YE, Nesterov VN, Krouchinsky NG et al. (1996) Human minisatellite mutation rate after the Chernobyl accident. Nature 380: 683-686
14. Gook DA, Osborn SM, Bourne H et al. (1994) Fertilization of human oocytes following cryopreservation; normal karyotypes and absence of stray chromosomes. Hum Reprod 9: 684-691
15. Gruijters MJ, Visser JA, Durlinger AL et al. (2003) Anti-Mullerian hormone and its role in ovarian function. Mol Cell Endocrinol 211: 85-90
16. Hawkins MM, Smith RA (1989) Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer 43: 399-402
17. Higdon RE, Marchetti F, Mailhes JB et al. The effects of cisplatin on murine metaphase II oocytes. Gynecol Oncol 47: 348-352
18. Katayama KP, Stele J, Kuwayama M et al. (2003) High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil Steril 80: 223-224
19. Katoh MA, Cain KT, Hughes LA et al. (1990) Female-specific dominant lethal effects in mice. Mutat Res 230: 205-217
20. Kim SS, Soules MR, Battaglia DE (2002) Follicular development, ovulation, and corpus luteum formation in cryopreserved human ovarian tissue after xenotransplantation. Fertil Steril 78: 77-82
21. Little MP, Charles MW, Wakeford R (1995) A review of the risks of leukemia in relation to parental pre-conception exposure to radiation. Health Phys 68: 299-310
22. Mailhes JB, Marchetti F, Young D (1995) Synergism between gonadotrophins and vinblastine relative to the frequencies of metaphase I, diploid and aneuploid mouse oocytes. Mutagenesis 10: 185-188
23. Meirow D, Schiff E (2005) Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data. J Natl Cancer Inst Monogr 34: 21-25
24. Meirow D, Fasouliotis SJ, Nugent D (1999) A laparoscopic technique for obtaining ovarian cortical biopsy specimens for fertility conservation in patients with cancer. Fertil Steril 71: 948-951
25. Meistrich ML, Byrne J (2002) Genetic disease in offspring of long-term survivors of childhood and adolescent cancer treated with potentially mutagenic therapies. Am J Hum Genet 70: 1069-1071
26. Mikkelsen AL, Smith S, Lindenberg S (2000) Impact of oestradiol and inhibin A concentrations on pregnancy rate in in-vitro oocyte maturation. Hum Reprod 15: 1685-1690
27. Morris ID (2002) Sperm DNA damage and cancer treatment. Int J Androl 25: 255-261
28. Oktay K, Buyuk E, Veeck L (2004) Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363: 837-8340
29. Oktay K, Buyuk E, Libertella N (2005) Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23: 4347-4353
30. Pereyra Pacheco B, Mendez Ribas JM, Milone G (2001) Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol 81: 391-397
31. Porcu E, Fabbri R, Maria Ciotti P (2002) Oocytes or embryo storage? Fertil Steril 78 [Suppl 1]: O38
32. Russo A, Levis AG (1992) Detection of aneuploidy in male germ cells of mice by means of a meiotic micronucleus assay. Mutat Res 281: 187-191
33. Schover LR (2005) Motivation for parenthood after cancer: a review. J Natl Cancer Inst Monogr 34: 2-5
34. Schover LR, Rybicki LA, Martin BA (1999) Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer 86: 6697-6709
35. Schover LR, Brey K, Lichtin A (2002) Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol 20: 1880-1889
36. Thibaud E, Ramirez M, Brauner R (1992) Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. J Pediatr 121: 880-884
37. von Wolff M, Eisenhardt S, Strowitzki T (2005) Ovarielle Protektion und Erhalt der Fertilität im Rahmen der Therapie gynäkologischer Malignome bei Kinder wunsch. Gynäkologische Endokrinologie 2: 107-114
38. Wallace WH, Shalet SM, Crowne EC (1989) Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol 1: 75-79
39. Wallace WH, Thomson AB, Kelsey TW (2003) The radiosensitivity of the human oocyte. Hum Reprod 18: 117-121
40. Waxman JH, Ahmed R, Smith D (1987) Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol 19: 159-162
41. Williams RS, Littell RD, Mendenhall NP (1999) Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease. Cancer 86: 2138-2142
42. Yang D, Winslow KL, Blohm PL (2002) Oocyte donation using cryopreserved donor oocytes. Fertil Steril 78 [Suppl 1]: O37